High number of CD45RO+ tumor infiltrating lymphocytes is an independent prognostic factor in non-metastasized (stage I-IIA) esophageal adenocarcinoma
- Sandra Rauser†1,
- Rupert Langer†2,
- Sebastian Tschernitz1,
- Peter Gais1,
- Uta Jütting3,
- Marcus Feith4,
- Heinz Höfler1, 2 and
- Axel Walch1Email author
© Rauser et al; licensee BioMed Central Ltd. 2010
Received: 11 May 2010
Accepted: 5 November 2010
Published: 5 November 2010
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|11 May 2010||Submitted||Original manuscript|
|8 Jul 2010||Reviewed||Reviewer Report - Hans Nijman|
|21 Jul 2010||Reviewed||Reviewer Report - Woo Ho Kim|
|17 Aug 2010||Author responded||Author comments - Rupert Langer|
|Resubmission - Version 2|
|17 Aug 2010||Submitted||Manuscript version 2|
|30 Sep 2010||Author responded||Author comments - Rupert Langer|
|Resubmission - Version 3|
|30 Sep 2010||Submitted||Manuscript version 3|
|15 Oct 2010||Author responded||Author comments - Rupert Langer|
|Resubmission - Version 4|
|15 Oct 2010||Submitted||Manuscript version 4|
|5 Nov 2010||Editorially accepted|
|5 Nov 2010||Article published||10.1186/1471-2407-10-608|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.